Tekcapital’s Microsalt has made an important step forward in the expansion of its global patent portfolio as the distribution of its low-sodium salt ramps up.
In half-year results released last week, Microsalt revealed increased demand from major B2B partners, and today’s news shows the company is gearing up for additional orders by protecting its technology in more jurisdictions.
The Tekcapital portfolio company has secured a Certificate of Invention Patent in China for its “Improved Low Sodium Salt Compositions” technology, now registered as Chinese Patent No. CN114206133.
Further developments include a Notice of Allowance received in Mexico for a similar patent application, with the final patent expected to be issued upon completion of fee payments. In Australia, MicroSalt’s patent application has entered a three-month opposition period, after which the company anticipates the patent will be granted if no objections are raised.
These international patents are all based on MicroSalt’s innovative low-sodium salt composition, which involves salt adhered to carrier particles through a specific production process. This technology is already patented in the United States under Patent No. 11,992,034.
MicroSalt is not stopping there, as the company revealed it has additional patent applications pending in several other countries, including Canada, Hong Kong, Chile, Japan, and various European nations.
“We are very pleased to witness the expansion of our intellectual property portfolio into some of the largest sodium markets in the world. We have made commercial inroads with customers in Asia, Europe and Australia and we see this development as very timely,” said Rick Guiney, CEO of MicroSalt.